MEDICAL PROPERTIES TRUST INC financial data

Symbol
MPT, MPW on NYSE
Location
Birmingham, AL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 218% % 27%
Return On Equity -5.9% % 86%
Return On Assets -1.8% % 88%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 597,700,000 shares -0.48%
Common Stock, Shares, Outstanding 597,008,000 shares -0.56%
Entity Public Float $2,600,000,000 USD 0%
Common Stock, Value, Issued $597,000 USD -0.5%
Weighted Average Number of Shares Outstanding, Basic 600,892,000 shares 0.11%
Weighted Average Number of Shares Outstanding, Diluted 600,892,000 shares 0.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $972,022,000 USD -2.4%
General and Administrative Expense $130,427,000 USD -2.5%
Costs and Expenses $942,609,000 USD -8.2%
Nonoperating Income (Expense) $266,732,000 USD 89%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $237,319,000 USD 90%
Income Tax Expense (Benefit) $38,618,000 USD -12%
Net Income (Loss) Attributable to Parent $277,049,000 USD 89%
Earnings Per Share, Basic -0.46 USD/shares 89%
Earnings Per Share, Diluted -0.46 USD/shares 89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $540,859,000 USD 63%
Assets $15,001,775,000 USD 4.9%
Liabilities $10,394,526,000 USD 9.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $168,213,000 USD
Retained Earnings (Accumulated Deficit) $4,136,011,000 USD -13%
Stockholders' Equity Attributable to Parent $4,606,195,000 USD -4.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,607,249,000 USD -4.7%
Liabilities and Equity $15,001,775,000 USD 4.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $384,000 USD -99%
Net Cash Provided by (Used in) Financing Activities $426,320,000 USD 1831%
Net Cash Provided by (Used in) Investing Activities $89,416,000 USD 25%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 597,008,000 shares -0.56%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Deferred Tax Assets, Valuation Allowance $489,604,000 USD 17%
Deferred Tax Assets, Gross $625,479,000 USD 15%
Operating Lease, Liability $71,995,000 USD -8.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $14,564,000 USD 99%
Lessee, Operating Lease, Liability, to be Paid $194,346,000 USD -7.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,567,000 USD -9.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,109,000 USD -12%
Operating Lease, Weighted Average Discount Rate, Percent 0.061 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $122,351,000 USD -7.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,648,000 USD -0.75%
Deferred Tax Assets, Operating Loss Carryforwards $334,501,000 USD 27%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,706,000 USD -1.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $65,431,000 USD -15%
Deferred Tax Assets, Net of Valuation Allowance $135,875,000 USD 9.4%
Interest Expense $510,362,000 USD 22%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%